C M Chu|Y F Liaw - JoVE Visualize

Showing results (31-40 of 328) with videos related to

Pageof 33

Sort By:

Gut|September 16, 1999

Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virusC M Chu, C T Yeh, Y F Liaw

Hepatology (Baltimore, Md.)|May 29, 2000

Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapyC T Yeh, R N Chien, C M Chu, et al.

Thorax|January 1, 1984

Jaundice after open heart surgery: a prospective studyC M Chu, C H Chang, Y F Liaw, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1993

Sex difference in chronic hepatitis B virus infection: studies of serum HBeAg and alanine aminotransferase levels in 10,431 asymptomatic Chinese HBsAg carriersC M Chu, I S Sheen, S M Lin, et al.

Alimentary Pharmacology & Therapeutics|December 1, 1996

A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patientsD Y Lin, I S Sheen, C M Chu, et al.

Journal of Hepatology|May 1, 1996

Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic studyI S Sheen, Y F Liaw, D Y Lin, et al.

Liver|June 1, 1987

Diagnosis of acute type B hepatitis by a solid phase u-antibody capture radioimmunoassay for IgM class antibody to hepatitis B core antigen: a diagnostic proposal based on a prospective studyC M Chu, Y F Liaw, C Y Yang, et al.

Biochemical and Biophysical Research Communications|September 15, 1994

Alteration of the subcellular localization of hepatitis B virus core protein by large but not small surface proteinsC T Yeh, J H Ou, C M Chu, et al.

Digestive Diseases and Sciences|January 1, 1995

Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseasesD Y Lin, C M Chu, I S Sheen, et al.

Infection|July 1, 1991

Acute hepatitis C virus superinfection followed by spontaneous HBeAg seroconversion and HBsAg eliminationY F Liaw, S M Lin, I S Sheen, et al.

Pageof 33

Showing results (31-40 of 328) with videos related to

Sort By:

Pageof 33

Gut|September 16, 1999

Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virusC M Chu, C T Yeh, Y F Liaw

Hepatology (Baltimore, Md.)|May 29, 2000

Clearance of the original hepatitis B virus YMDD-motif mutants with emergence of distinct lamivudine-resistant mutants during prolonged lamivudine therapyC T Yeh, R N Chien, C M Chu, et al.

Thorax|January 1, 1984

Jaundice after open heart surgery: a prospective studyC M Chu, C H Chang, Y F Liaw, et al.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 1, 1993

Sex difference in chronic hepatitis B virus infection: studies of serum HBeAg and alanine aminotransferase levels in 10,431 asymptomatic Chinese HBsAg carriersC M Chu, I S Sheen, S M Lin, et al.

Alimentary Pharmacology & Therapeutics|December 1, 1996

A prospective randomized trial of colchicine in prevention of liver cirrhosis in chronic hepatitis B patientsD Y Lin, I S Sheen, C M Chu, et al.

Journal of Hepatology|May 1, 1996

Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic studyI S Sheen, Y F Liaw, D Y Lin, et al.

Liver|June 1, 1987

Diagnosis of acute type B hepatitis by a solid phase u-antibody capture radioimmunoassay for IgM class antibody to hepatitis B core antigen: a diagnostic proposal based on a prospective studyC M Chu, Y F Liaw, C Y Yang, et al.

Biochemical and Biophysical Research Communications|September 15, 1994

Alteration of the subcellular localization of hepatitis B virus core protein by large but not small surface proteinsC T Yeh, J H Ou, C M Chu, et al.

Digestive Diseases and Sciences|January 1, 1995

Serum carboxy terminal propeptide of type I procollagen to amino terminal propeptide of type III procollagen ratio is a better indicator than each single propeptide and 7S domain type IV collagen for progressive fibrogenesis in chronic viral liver diseasesD Y Lin, C M Chu, I S Sheen, et al.

Infection|July 1, 1991

Acute hepatitis C virus superinfection followed by spontaneous HBeAg seroconversion and HBsAg eliminationY F Liaw, S M Lin, I S Sheen, et al.

Pageof 33